53 related articles for article (PubMed ID: 16282208)
1. Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans.
Perkins A; Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL; Cuenca-Estrella M
J Antimicrob Chemother; 2005 Dec; 56(6):1144-7. PubMed ID: 16282208
[TBL] [Abstract][Full Text] [Related]
2. In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Illnait-Zaragozi MT; Martínez GF; Curfs-Breuker I; Fernández CM; Boekhout T; Meis JF
Antimicrob Agents Chemother; 2008 Apr; 52(4):1580-2. PubMed ID: 18212095
[TBL] [Abstract][Full Text] [Related]
3. Unraveling Caspofungin Resistance in Cryptococcus neoformans.
Papon N; Goldman GH
mBio; 2021 Mar; 12(2):. PubMed ID: 33727346
[No Abstract] [Full Text] [Related]
4. Proteomics reveals that the antifungal activity of fenbendazole against Cryptococcus neoformans requires protein kinases.
de Oliveira HC; Santos MDM; Camillo-Andrade AC; Castelli RF; Dos Reis FCG; Carvalho PC; Rodrigues ML
Int J Antimicrob Agents; 2024 May; 63(5):107157. PubMed ID: 38548248
[TBL] [Abstract][Full Text] [Related]
5. Specific activities of dolastatin 10 and peptide derivatives against Cryptococcus neoformans.
Pettit RK; Pettit GR; Hazen KC
Antimicrob Agents Chemother; 1998 Nov; 42(11):2961-5. PubMed ID: 9797233
[TBL] [Abstract][Full Text] [Related]
6. Activities of available and investigational antifungal agents against rhodotorula species.
Diekema DJ; Petroelje B; Messer SA; Hollis RJ; Pfaller MA
J Clin Microbiol; 2005 Jan; 43(1):476-8. PubMed ID: 15635020
[TBL] [Abstract][Full Text] [Related]
7. Synthetically modified L-histidine-rich peptidomimetics exhibit potent activity against Cryptococcus neoformans.
Mahindra A; Bagra N; Wangoo N; Jain R; Khan SI; Jacob MR; Jain R
Bioorg Med Chem Lett; 2014 Jul; 24(14):3150-4. PubMed ID: 24878194
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Resistance in Cryptococcal Infections.
Melhem MSC; Leite Júnior DP; Takahashi JPF; Macioni MB; Oliveira L; de Araújo LS; Fava WS; Bonfietti LX; Paniago AMM; Venturini J; Espinel-Ingroff A
Pathogens; 2024 Jan; 13(2):. PubMed ID: 38392866
[TBL] [Abstract][Full Text] [Related]
9. Methods for Antifungal Susceptibility Testing of the
Espinel-Ingroff A; Cantón E
J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233253
[TBL] [Abstract][Full Text] [Related]
10.
Al-Odaini N; Li XY; Li BK; Chen XC; Huang CY; Lv CY; Pan KS; Zheng DY; Zheng YQ; Liao WQ; Cao CW
Front Microbiol; 2021; 12():708280. PubMed ID: 34447360
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B and Other Polyenes-Discovery, Clinical Use, Mode of Action and Drug Resistance.
Carolus H; Pierson S; Lagrou K; Van Dijck P
J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33261213
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis in immunocompetent and immunocompromised patients with pulmonary cryptococcosis in western China.
Qu J; Zhang X; Lu Y; Liu X; Lv X
Sci Rep; 2020 Jun; 10(1):9387. PubMed ID: 32523003
[TBL] [Abstract][Full Text] [Related]
13. New Approaches for Cryptococcosis Treatment.
Spadari CC; Wirth F; Lopes LB; Ishida K
Microorganisms; 2020 Apr; 8(4):. PubMed ID: 32340403
[TBL] [Abstract][Full Text] [Related]
14. First Isolation, Antifungal Susceptibility, and Molecular Characterization of
Pllana-Hajdari D; Cogliati M; Čičmak L; Pleško S; Mlinarić-Missoni E; Mareković I
J Fungi (Basel); 2019 Oct; 5(4):. PubMed ID: 31614885
[TBL] [Abstract][Full Text] [Related]
15. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
[TBL] [Abstract][Full Text] [Related]
16. Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species.
Melhem MS; Bertoletti A; Lucca HR; Silva RB; Meneghin FA; Szeszs MW
Braz J Microbiol; 2013 Dec; 44(4):1257-66. PubMed ID: 24688520
[TBL] [Abstract][Full Text] [Related]
17. Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.
de Aguiar Cordeiro R; Mourão CI; Rocha MF; de Farias Marques FJ; Teixeira CE; de Oliveira Miranda DF; Neto LV; Brilhante RS; de Jesus Pinheiro Gomes Bandeira T; Sidrim JJ
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):557-64. PubMed ID: 23192488
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.
Espinel-Ingroff A; Chowdhary A; Cuenca-Estrella M; Fothergill A; Fuller J; Hagen F; Govender N; Guarro J; Johnson E; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; Trilles L; Kidd S; Turnidge J
Antimicrob Agents Chemother; 2012 Jun; 56(6):3107-13. PubMed ID: 22391546
[TBL] [Abstract][Full Text] [Related]
20. Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.
Matos CS; de Souza Andrade A; Oliveira NS; Barros TF
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1647-52. PubMed ID: 22278291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
